Your diabetic patients may have more difficulty obtaining their test strips following an OIG crackdown on supplier billing for the items. Background:
"Claims in CBAs for the more expensive, non-mail order DTS increased by 33 percent from 2010 to 2011, while claims for the less expensive, mail order DTS decreased by 71 percent," the OIG reports. "Further, for 20 percent of beneficiaries in our review, suppliers improperly billed Medicare for the more expensive, non-mail order DTS in 2011, but beneficiaries reported having instead received the less expensive, mail order DTS."
The report is online at https://oig.hhs.gov/oei/reports/oei-04-11-00760.pdf.